2027 Best Value Pharmaceutical Sciences Schools in the Far Western Region
Pharmaceutical Sciences degree programs vary widely in price and payoff across the country. The best values balance affordable tuition against strong post-graduation earnings.
College Factual analyzed 8 schools to build this 2027 ranking of the best value pharmaceutical sciences schools.
What’s on this page:
2027 Best Value Pharmaceutical Sciences Schools in the Far Western Region
If you want to know which schools deliver the best value for the pharmaceutical sciences degrees they offer, see the list below.
Best Value Pharmaceutical Sciences Schools
University Of Washington Seattle Campus earned the #1 spot for value among pharmaceutical sciences schools in the Far Western Region. Set in the city of Seattle, University Of Washington Seattle Campus is a very large public institution. In-state tuition and fees average $12,973, while out-of-state students pay about $43,209. Pharmaceutical Sciences graduates carry a median of $16,481 in student loans. Soon after graduation, pharmaceutical sciences degree recipients from University Of Washington Seattle Campus generally make around $65,681. That is a strong return on a $16,481 median debt. Roughly 39% of applicants are accepted.
The strong cost-to-outcome balance at University Of California Irvine earned it the #2 place for pharmaceutical sciences. Located in the city of Irvine, University Of California Irvine is a very large public university. The average in-state cost of tuition and fees is $14,752, compared with $46,640 for out-of-state students. Students borrow a median of $15,026 to complete the pharmaceutical sciences program here. Soon after graduation, pharmaceutical sciences degree recipients from University Of California Irvine generally make around $20,538. Weighed against typical debt, the earnings make a compelling case for value. Roughly 29% of applicants are accepted.
The strong cost-to-outcome balance at University Of California Davis earned it the #3 place for pharmaceutical sciences. University Of California Davis is a very large public school located in the suburb of Davis. In-state tuition and fees average $15,804, compared with $47,692 for out-of-state students. Typical student debt for pharmaceutical sciences graduates is $13,470. Early-career pharmaceutical sciences graduates make about $40,002. Set against $13,470 in median debt, that is a healthy payoff. The acceptance rate is 42%.
Washington State University is a great value for students pursuing a degree in pharmaceutical sciences, landing the #4 spot this year. Located in the town of Pullman, Washington State University is a very large public university. Students from in state pay about $13,391 in tuition and fees, compared with $29,950 for out-of-state students. Typical student debt for pharmaceutical sciences graduates is $21,903. Pharmaceutical Sciences graduates of Washington State University earn a median of $117,376 early in their careers. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 87%.
Students looking for strong value in pharmaceutical sciences will find it at Oregon State University, which ranked #5. Set in the city of Corvallis, Oregon State University is a very large public institution. Students from in state pay about $14,400 in tuition and fees, while out-of-state students pay about $38,190. Typical student debt for pharmaceutical sciences graduates is $24,041. Early-career pharmaceutical sciences graduates make about $110,269. Set against $24,041 in median debt, that is a healthy payoff. Roughly 77% of applicants are accepted.
University Of Southern California came in at #6 for value in pharmaceutical sciences this year. University Of Southern California is a very large private not-for-profit school located in the city of Los Angeles. Students from in state pay about $71,647 in tuition and fees. Typical student debt for pharmaceutical sciences graduates is $15,625. Soon after graduation, pharmaceutical sciences degree recipients from University Of Southern California generally make around $114,101. That is a strong return on a $15,625 median debt. University Of Southern California admits about 10% of applicants.
Pacific University earned the #7 position for value in pharmaceutical sciences this year. Set in the suburb of Forest Grove, Pacific University is a mid-sized private not-for-profit institution. In-state tuition and fees average $56,374. Students borrow a median of $26,170 to complete the pharmaceutical sciences program here. Early-career pharmaceutical sciences graduates make about $95,669. That is a strong return on a $26,170 median debt. The acceptance rate is 90%.
Chapman University landed the #8 spot for pharmaceutical sciences value this year. Located in the city of Orange, Chapman University is a large private not-for-profit university. Students from in state pay about $64,984 in tuition and fees. Typical student debt for pharmaceutical sciences graduates is $21,657. Pharmaceutical Sciences graduates of Chapman University earn a median of $78,465 early in their careers. Set against $21,657 in median debt, that is a healthy payoff. Chapman University admits about 65% of applicants.
Narrow Pharmaceutical Sciences Schools by State
More Pharmaceutical Sciences Rankings
View All Pharmaceutical Sciences Rankings >
Notes and References
This ranking is produced by College Factual (MF_RANKING_2025), 2027 edition. The methodology weighs the cost of a degree against the earnings graduates go on to achieve, drawn primarily from the U.S. Department of Education (IPEDS and College Scorecard).
Ranking method: College Major Best Value · 8 schools evaluated.
*Averages shown above reflect the top 8 ranked schools only.
- The Integrated Postsecondary Education Data System (IPEDS) from the National Center for Education Statistics (NCES), a branch of the U.S. Department of Education (DOE), serves as the core of our data about colleges.
- Some other college data, including much of the graduate earnings data, comes from the U.S. Department of Education’s (College Scorecard).
More about our data sources and methodologies.